Zyprexa

   
Google
 
Web NewDrugInformation.com

Zyprexa


Drug - Zyprexa
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Olanzapine
Multiple ingredients are in alphabetical order.

Strength - 5MG
The potency of the active ingredient(s), Olanzapine. May repeat for multiple part products.

Applicant - LILLY
The firm name holding legal responsibility for Zyprexa. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020592
The FDA assigned number to Zyprexa. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Zyprexa. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 30, 1996
The date Zyprexa was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Zyprexa. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Zyprexa is in. Format is RX, OTC, DISCN.

Applicant Full Name - Eli Lilly And Co
The full name of the firm holding legal responsibility for the new application of Zyprexa.

Zyprexa